|
|
||||||||
1Vascular Biology Center and Departments of 2Physiology, 3Pharmacology, and 4Surgery, Medical College of Georgia, Augusta, Georgia
Submitted 19 August 2004 ; accepted in final form 18 November 2004
Clinical studies have documented an abrupt rise in plasma endothelin-1 (ET-1) coincident with an increase in mean arterial pressure (MAP) during the response to acute stress. We therefore examined the ETA and ETB receptor-dependent effects of ET-1 on the pressor response to acute environmental stress in ET-1-dependent hypertension. Stress was induced by administration of air jet pulses (3 min) in ETB receptor-deficient (ETB sl/sl) rats fed normal salt (NS; 0.8% NaCl), high salt (HS; 8% NaCl), and HS plus the ETA receptor antagonist ABT-627 (5 mg·kg1·day1) on successive weeks. MAP was chronically monitored by telemetry. Total pressor response (area under the curve) was significantly reduced in ETB sl/sl rats maintained on a HS vs. NS diet [6.8 mmHg (SD 18.7) vs. 29.3 mmHg (SD 8.1) x 3 min, P < 0.05]. Conversely, the total pressor response was augmented in both wild-type [34.2 mmHg (SD 29.2) x 3 min, P < 0.05 vs. NS] and ETB sl/sl rats [49.1 mmHg (SD 11.8) x 3 min, P < 0.05 vs. NS] by ABT-627. Blockade of ETB receptors in Sprague-Dawley rats caused an increase in basal MAP that was enhanced by HS and lowered by mixed ETA/ETB receptor antagonism; none of these treatments, however, had any effect on the pressor response. These data demonstrate that increasing endogenous ET-1 suppresses the pressor response to acute stress through ETA receptor activation in a genetic model of ET-1-dependent hypertension. These results are consistent with reports that ET-1 can attenuate sympathetically mediated responses.
adrenergic; salt-sensitive hypertension; sympathetic nervous system
This article has been cited by other articles:
![]() |
S. B. Bender and R. E. Klabunde Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and {alpha}1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2281 - H2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Opocensky, H. J. Kramer, A. Backer, Z. Vernerova, V. Eis, L. Cervenka, V. Certikova Chabova, V. Tesar, and I. Vaneckova Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension Hypertension, November 1, 2006; 48(5): 965 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Angelo, J. S. Pollock, and D. M. Pollock In vivo evidence for endothelin-1-mediated attenuation of {alpha}1-adrenergic stimulation Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1251 - H1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vaneckova, H. J. Kramer, A. Backer, Z. Vernerova, M. Opocensky, and L. Cervenka Early Endothelin-A Receptor Blockade Decreases Blood Pressure and Ameliorates End-Organ Damage in Homozygous Ren-2 Rats Hypertension, October 1, 2005; 46(4): 969 - 974. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |